|
Norfloxacin
|
A synthetic fluoroquinolone (fluoroquinolones) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA gyrase. (PubChem) Pharmacology: Norfloxacin is a quinolone/fluoroquinolone antibiotic. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Mechanism of action: The bactericidal action of Norfloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination. Norfloxacin is a broad-spectrum antibiotic that is active against both gram-positive and gram-negative bacterias. The fluorine atom at the 6 position increases potency against gram-negative organisms, and the piperazine moiety at the 7 position is responsible for anti-pseudomonal activity Drug type: Approved. Small Molecule. Drug category: Anti-Bacterial Agents. Anti-Infectives. Enzyme Inhibitors. Nucleic Acid Synthesis Inhibitors. Quinolones
|
ILX:0107682
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Norgestimate
|
Norgestimate is a form of progesterone, which is a female hormone important for the regulation of ovulation and menstruation. Norgestimate is used with estradiol to treat the symptoms of menopause. Pharmacology: Norgestimate is used as a female contraceptive. Norgestimate is a progestin or a synthetic form of the naturally occurring female sex hormone, progesterone. In a woman's normal menstrual cycle, an egg matures and is released from the ovaries (ovulation). The ovary then produces progesterone, preventing the release of further eggs and priming the lining of the womb for a possible pregnancy. If pregnancy occurs, progesterone levels in the body remain high, maintaining the womb lining. If pregnancy does not occur, progesterone levels in the body fall, resulting in a menstrual period. Norgestimate tricks the body processes into thinking that ovulation has already occurred, by maintaining high levels of the synthetic progesterone. This prevents the release of eggs from the ovaries. Mechanism of action: Norgestimate binds to androgen and progestogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like Norgestimate will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge. Drug type: Approved. Small Molecule. Drug category: Contraceptives. Contraceptives, Oral, Synthetic
|
ILX:0107683
|
4
|
FDI Lab - SciCrunch.org
|
08/24/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
troy sincomb |
|
Norgestrel
|
A synthetic progestational hormone with actions similar to those of progesterone and about twice as potent as its racemic or (+-)-isomer (norgestrel). It is used for contraception, control of menstrual disorders, and treatment of endometriosis. (PubChem) Pharmacology: Norgestrel is used as a female contraceptive. Norgestrel is a progestin or a synthetic form of the naturally occurring female sex hormone, progesterone. In a woman's normal menstrual cycle, an egg matures and is released from the ovaries (ovulation). The ovary then produces progesterone, preventing the release of further eggs and priming the lining of the womb for a possible pregnancy. If pregnancy occurs, progesterone levels in the body remain high, maintaining the womb lining. If pregnancy does not occur, progesterone levels in the body fall, resulting in a menstrual period. Norgestrel tricks the body processes into thinking that ovulation has already occurred, by maintaining high levels of the synthetic progesterone. This prevents the release of eggs from the ovaries. Mechanism of action: Norgestrel binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like Norgestrel will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge. Drug type: Approved. Small Molecule. Drug category: Contraceptive Agents, Female. Contraceptives. Contraceptives, Oral, Synthetic
|
ILX:0107684
|
4
|
FDI Lab - SciCrunch.org
|
08/24/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
troy sincomb |
|
Normal
|
|
ILX:0107685
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Normalization Point
|
Coordinates (x, y, z) of normalization point in the patient based coordinate system described in (mm).
|
ILX:0107686
|
5
|
FDI Lab - SciCrunch.org
|
08/28/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
troy sincomb |
|
North American Biobank
|
A cryogenic storage facility located in North America used to archive biological samples for use in research and experiments or transplantation. Ranging in size from individual refrigerators to warehouses, North American biobanks are maintained by institutions such as hospitals, universities, nonprofit organizations, and pharmaceutical companies. (Adapted from Wikipedia)
|
ILX:0107687
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
North East Cyberinfrastructure Consortium
|
A consortium of five states that are collaborating on building cyberinfrastructure in the NE region. The consortium is not formally affiliated with NSF EPSCoR or the NIH IDeA.
|
ILX:0107688
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Northern Antibiotics
|
Commercial organization headquartered in Helsinki, Finland, that engages in the discovery and development of antibiotics against multidrug-resistant gram-negative bacteria. It develops compounds, which are active against difficult-to-treat gram-negative bacteria, such as multi-resistant Escherichia coli, Klebsiella pneumoniae, other species of Enterobacteriaceae, and Acinetobacter baumannii. (Adapted from Bloomberg Businessweek)
|
ILX:0107689
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Northern clearwater crayfish
|
|
ILX:0107690
|
5
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Nortriptyline
|
A metabolite of amitriptyline that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions. (PubChem) Pharmacology: Similar to protriptyline, nortriptyline is a tricyclic antidepressant of the dibenzocycloheptene type and is the active metabolite of amitriptyline. Mechanism of action: It is believed that nortriptyline either inhibits the reuptake of the neurotransmitter serotonin at the neuronal membrane or acts at beta-adrenergic receptors. Tricyclic antidepressants do not inhibit monoamine oxidase nor do they affect dopamine reuptake. Drug type: Approved. Small Molecule. Drug category: Adrenergic Uptake Inhibitors. Antidepressants. Antidepressive Agents, Tricyclic. Norepinephrine-Reuptake Inhibitors
|
ILX:0107691
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Notaspidea
|
|
ILX:0107692
|
6
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Notch filter
|
Filtering of signal within a small range, usually 60Hz. Power lines emit 60Hz signals that interfere with signal measurement in this range.
|
ILX:0107693
|
5
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Notch Filter Bandwidth
|
Nominal 3dB bandwidth of notch filter(s) in Hz.
|
ILX:0107694
|
4
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Notch Filter Frequency
|
Center frequency of notch filter(s) in Hz.
|
ILX:0107695
|
4
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Notched
|
Concave shape which is a V-shaped cut.
|
ILX:0107696
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Note
|
A resource that provides notes that relate to neuroscience, such as from an introductory neurobiology course.
|
ILX:0107697
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Novartis
|
A Swiss multinational pharmaceutical company dedicated to the research and development of new drugs. The businesses of Novartis are divided into six operating divisions: Pharmaceuticals, Alcon (eye care), Vaccines and Diagnostics, Sandoz (generics), Consumer (divided into two divisions: Over-the-Counter and Animal Health), and Corporate. (Adapted from Wikipedia)
|
ILX:0107698
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Novelty suppressed feeding test.
|
|
ILX:0107699
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Novo Nordisk
|
A Danish multinational pharmaceutical company that manufactures and markets pharmaceutical products and services. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. The company makes several drugs under various brand names, including Levemir, NovoLog, Novolin R, NovoSeven, NovoEight and Victoza. (Adapted from Wikipedia)
|
ILX:0107700
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Novobiocin
|
An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189) (PubChem) Pharmacology: Novobiocin is an aminocoumarin antibiotic that was produced by the actinomycete Streptomyces niveus. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. Other antibiotics in the aminocoumarin class include coumermycin A1 and clorobiocin. Mechanism of action: Novobiocin is an aminocoumarin. Aminocoumarins are very potent inhibitors of bacterial DNA gyrase and work by targeting the GyrB subunit of the enzyme involved in energy tranduction. Novobiocin as well as the other aminocoumarin antibiotics act as competitive inhibitors of the ATPase reaction catalysed by GyrB. Drug type: Approved. Small Molecule. Drug category: Anti-Bacterial Agents. Enzyme Inhibitors. Nucleic Acid Synthesis Inhibitors
|
ILX:0107701
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |